Skip to content

Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation

The Study to Compare Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03078140
Enrollment
208
Registered
2017-03-13
Start date
2017-05-01
Completion date
2018-05-31
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iodine Deficiency, Pregnancy Related

Brief summary

Pregnant women who attend at our antenatal clinic will random to 2 groups. First will receive routine iodine supplementation. The other will receive iodinated pill or only iron supplementation base on their urine iodine status.

Interventions

DIETARY_SUPPLEMENTTriferdine

Triferdine 1 tablet daily Start from 14 weeks of gestation until delivery

DIETARY_SUPPLEMENTTriferdine/Ferli-6

For the participants assigned to this group, urine iodine level will be checked first. For participants with normal urine iodine level, Ferli-6 1 tab daily will be given. For those with low urine iodine level, Triferdine 1 tab daily will be given. Medication will be started from 14 weeks of gestation until delivery.

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* first visit for antenatal care in the first trimester * singleton pregnancy * delivered at Maharaj Nakorn Chiangmai Hospital

Exclusion criteria

* thyroid disease which diagnosed before pregnancy or currently * history of thyroid gland surgery or iodine ablation therapy * received iodine supplement before pregnancy * received any medication for thyroid disease treatment, within 6 weeks postpartum women or breast feeding period * family history of thyroid disease * having underlying disease or contraindication which cannot received iodine supplement * loss follow-up or incomplete data.

Design outcomes

Primary

MeasureTime frameDescription
iodine statusat deliverymean urine iodine

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026